tg 2

TG-2-IN-1 (Compound D003) is a transglutaminase-2 ( TGM-2 ) inhibitor. TG-2-IN-1 can be used in myopia research[1].

6-Thioguanine (2-Amino-6-purinethiol) is an antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.

PROTAC TG2 degrader-2 (compound 7) is a selective competitive degrader of Transglutaminase 2 (TG2), exhibiting a dissociation constant (Kd) greater than 100 μM. It inhibits cell migration and reduces TG2 levels in ovarian cancer cells, making it a valuable tool for ovarian cancer research [1].

1-Myristoyl-2-linoleoyl-3-oleoyl-rac-glycerol, a triacylglycerol, features myristic acid, linoleic acid, and oleic acid at the sn-1, sn-2, and sn-3 positions, respectively. This compound is prevalent in mature human milk, infant formula fats, and butterfat.

1-Palmitoyl-2-arachidoyl-3-oleoyl-rac-glycerol, a triacylglycerol, incorporates palmitic acid, arachidic acid, and oleic acid at the sn-1, sn-2, and sn-3 positions, respectively, and is identified in cod liver oil.

1,3-Dioleoyl-2-octanoyl glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-3 positions and octanoic acid at the sn-2 position. Its utility lies in the characterization of R. oryzae lipase functionality, specifically for regiodistribution analysis of fats that comprise medium- and short-chain fatty acids.

1,3-Dioleoyl-2-myristoyl glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-3 positions and myristic acid at the sn-2 position, and is identified in palm oil.

1,2-Dioleoyl-3-linoleoyl-rac-glycerol (OOL) is a triglyceride featuring oleic acid at the sn-1 and sn-2 positions and linoleic acid at the sn-3 position. This compound is prevalent in several seed and vegetable oils, such as those from pumpkin seeds, olives, and sesame.

2-Myristyldistearin (SMS), a triacylglycerol comprising myristic acid and stearic acid [1], showcases its intricate structural composition.

1-Palmitoyl-2-linoleoyl-3-stearoyl-rac-glycerol, a triacylglycerol, comprises palmitic acid (at the sn-1 position), linoleic acid (at the sn-2 position), and stearic acid (at the sn-3 position). This compound is present in mature human milk and various plant oils.

1,3-Dioleoyl-2-heptadecanoyl glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-3 positions and heptadecanoic acid at the sn-2 position.

1,3-Dimyristoyl-2-oleoyl glycerol, a triacylglycerol featuring myristic acid at the sn-1 and sn-3 positions and oleic acid at the sn-2 position, is identified in date seed oil.

1-Palmitoyl-2-stearoyl-3-butyryl-rac-glycerol is a triacylglycerol that incorporates palmitic acid, stearic acid, and butyric acid at the sn-1, sn-2, and sn-3 positions, respectively. This compound serves as a substrate to establish the stereospecificity and typoselectivity of lipases.

1-Oleoyl-2-palmitoyl-3-linoleoyl-rac-glycerol is a triacylglycerol comprising oleic acid [at the sn-1 position], palmitic acid [at the sn-2 position], and linoleic acid [at the sn-3 position], identified in bovine milk fat.

1-Myristoyl-2-linoleoyl-3-palmitoyl-rac-glycerol, a triacylglycerol comprising myristic, linoleic, and palmitic acids at the sn-1, sn-2, and sn-3 positions respectively, is present in palm and vegetable oils.

1-Arachidoyl-2-palmitoyl-3-oleoyl-rac-glycerol, a triacylglycerol, incorporates arachidic, palmitic, and oleic acids at the sn-1, sn-2, and sn-3 positions, respectively. It is present in butterfat and exhibits elevated liver levels in Plin5-overexpressing mice subjected to a high-fat diet.

1,3-Distearoyl-2-palmitoyl glycerol, a triacylglycerol, comprises stearic acid at the sn-1 and sn-3 positions, and palmitic acid at the sn-2 position. This compound is present in bovine milk fat.

1,3-Dilinoleoyl-2-stearoyl glycerol, a triacylglycerol, incorporates linoleic acid at the sn-1 and sn-3 positions and stearic acid at the sn-2 position. This compound is present in soybean oil and both transitional and mature human milk.

1-Stearoyl-2-oleoyl-3-linoleoyl-rac-glycerol is a triacylglycerol consisting of stearic acid, oleic acid, and linoleic acid esterified at the sn-1, sn-2, and sn-3 positions, respectively. This compound is present in peanut and soybean oils as well as in ostrich and emu oils. Additionally, it serves as a substrate for soybean lipoxygenase in cell-free assays.

1-Palmitoyl-2-oleoyl-3-stearoyl-rac-glycerol, a primary triacylglycerol in cocoa butter, features palmitic acid (at the sn-1 position), oleic acid (at the sn-2 position), and stearic acid (at the sn-3 position).

1,3-Distearoyl-2-linoleoyl glycerol, a triacylglycerol, features stearic acid at the sn-1 and sn-3 positions and linoleic acid at the sn-2 position. This compound is present in cocoa butter and in cocoa butter equivalents (CBEs) that include shea stearin and palm mid fraction.

1-Palmitoyl-2-elaidoyl-3-linoleoyl-rac-glycerol is a triacylglycerol composed of palmitic acid (at the sn-1 position), elaidic acid (at the sn-2 position), and linoleic acid (at the sn-3 position) respectively.

1-Palmitoyl-2-oleoyl-3-linolenoyl-rac-glycerol is a triacylglycerol comprising palmitic acid, oleic acid, and α-linolenic acid esterified at the sn-1, sn-2, and sn-3 positions, respectively.

1-Stearoyl-2-palmitoyl-3-oleoyl-rac-glycerol is a triacylglycerol comprising stearic acid (at the sn-1 position), palmitic acid (at the sn-2 position), and oleic acid (at the sn-3 position), identified in bovine milk.

1,3-Dipalmitoyl-2-oleoyl glycerol, a triacylglycerol, incorporates palmitic acid in the sn-1 and sn-3 positions and oleic acid in the sn-2 position. This compound is present in cocoa butter, Chinese tallow butter, and the palm stearin fraction of palm oil.

1,3-Dioleoyl-2-stearoyl glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-3 positions and stearic acid at the sn-2 position, and is identified in butterfat.

1,3-Didocosanoyl-2-oleoyl glycerol, a triacylglycerol, incorporates docosanoic acid at the sn-1 and sn-3 positions and oleic acid at the sn-2 position. Present in cocoa butter, its use as a seed material in dark chocolate enhances solidification rates and inhibits fat bloom formation.

2-Myristyl dipalmitin (PMP), a triglyceride of palmitic acid, shows potential as a lipid marker for Wilson's disease (WD) [1] [2].

1,3-Dipalmitoyl-2-stearoyl glycerol, a triacylglycerol, incorporates palmitic acid at the sn-1 and sn-3 positions and stearic acid at the sn-2 position. This compound's levels diminish in rats experiencing an energy deficit due to restricted food intake, in contrast to those in fed rats.

1,3-Dioleoyl-2-linoleoyl glycerol, a triacylglycerol, features oleic acid at the sn-1 and sn-3 positions and linoleic acid at the sn-2 position. This compound is a prominent species in butterfat and is present in A. trifoliata seed oil (ASO), along with smaller amounts in its physical blends and interesterified products.

1,3-Dimyristoyl-2-eicosapentaenoyl glycerol (MEM) is a triacylglycerol with myristic acid at the sn-1 and sn-3 positions and eicosapentaenoic acid at the sn-2 position. The presence of myristoyl groups in MEM does not impact the oxidative stability of eicosapentaenoic acid (EPA) during prolonged storage at 25°C.

1,3-Dipalmitoyl-2-docosahexaenoyl glycerol, a triacylglycerol, features palmitic acid at the sn-1 and sn-3 positions and docosahexaenoic acid at the sn-2 position. Its dietary administration (30 g/kg) has been shown to decrease hepatic triglyceride and cholesterol levels in mice.

1,2-Dilinoleoyl-3-oleoyl-rac-glycerol, a triacylglycerol, comprises linoleic acid at the sn-1 and sn-2 positions and oleic acid at the sn-3 position. This compound is present in the oils of ostrich and emu, and the fat body of male B. lapidarius bumblebees. It demonstrates efficacy in reducing scald development in Delicious apples, showing a 3% w/v reduction when applied immediately after harvest and evaluated after six months of storage.

1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol is a triacylglycerol featuring linoleic acid at the sn-1 and sn-2 positions and palmitic acid at the sn-3 position. Present in various vegetable oils such as poppy seed, hazelnut, maize, and olive, this compound (3% w/v) effectively reduces scald development in Delicious apples when applied right after harvest, with results observed after six months of storage.

1,3-Dipalmitoyl-2-linoleoyl glycerol is a triacylglycerol featuring palmitic acid at the sn-1 and sn-3 positions, and linoleic acid at the sn-2 position. Identified within the palm stearin fraction of palm oil and as a trace constituent in soybean germ oil, this compound exemplifies the structural diversity of fats and oils in both plant-based sources.

1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol, a triacylglycerol with myristic acid (at the sn-1 position), palmitic acid (at the sn-2 position), and butyric acid (at the sn-3 position), has been detected in human breast milk.

1,2-Dilinoleoyl-3-stearoyl-rac-glycerol, a triacylglycerol, comprises linoleic acid at the sn-1 and sn-2 positions and stearic acid at the sn-3 position. It is present in various plant oils such as soybean, poppy seed, maize, evening primrose, and blackcurrant.

1,2-Dipalmitoyl-3-linoleoyl-rac-glycerol, a triacylglycerol, features palmitic acid at the sn-1 and sn-2 positions and linoleic acid at the sn-3 position. This compound is present in ostrich and emu oils as well as in bovine milk fat.

TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor that effectively hampers BAP1's deubiquitinase activity in cell-free assays at concentrations between 25 µM and 1.5 mM. This compound exhibits cytotoxicity towards a range of eight colon cancer cell lines, with half-maximal inhibitory concentrations (IC50s) spanning from 4.48 to 7.52 µM. Additionally, in an HCT116 colon cancer mouse xenograft model, TG2-179-1 administration at doses of 10 and 30 mg/kg significantly reduces tumor volume, demonstrating its potential in vivo efficacy against colon cancer.

AA9 is a novel transglutaminase (TG2) inhibitor.

PROTAC TG2 Degrader-1 (Compound 11) is a VHL-based PROTAC that targets tissue transglutaminase (TG2) and exhibits a binding affinity with a K D of 68.9 μM. This compound effectively decreases TG2 levels in ovarian cancer cells through a proteasome-dependent pathway [1].

VA4 is a novel irreversible TG2 transamidase site-specific inhibitor.

TG2-IN-3h is a highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (tg2) inhibitor

TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively).

BDC2.5 mimotope 1040-31 TFA, a specific agonistic peptide for the diabetogenic T cell clone BDC2.5, exhibits strong reactivity with BDC2.5 T-cell receptor (TCR) transgenic (Tg)+ T cells [1] [2].

Salvifaricin, an orally active diterpenoid isolated from Salvia leucantha Cav. and Salvia hispanica L., significantly lowers fasting blood glucose and serum triglyceride (TG) levels, exhibiting an anti-diabetic effect [1] [2].

TG 100572 is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively).

1. Dehydroabietic acid (Dehydroabietate) (DAA) is an EBV-EA activation inhibitor. 2. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. 3. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.

PPARγ-IN-2 (Compound 5a), a PPARγ inhibitor, exhibits an EC50 of 0.106 μM in inhibiting TG accumulation in 3T3-L1 preadipocytes. Furthermore, PPARγ-IN-2 counteracts obesity and associated metabolic syndrome induced by a high-fat cholesterol (HFC) diet and diminishes lipid accumulation in adipose tissue [1].

Tridocosahexaenoylglycerol (TG-DHA), an orally active dietary supplement, enhances outcomes in autoimmune encephalomyelitis among mice, exhibits beneficial impacts on neurodegenerative conditions, and fosters macular function improvement in diabetic retinopathy. It is applicable for investigating neurological, inflammatory immune, and metabolic diseases [1] [2] [3].